Optimer Pharmaceuticals, Inc. Reports Second Quarter 2013 Financial Results

Published: Aug 01, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

JERSEY CITY, N.J., Aug. 1, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. OPTR announced today unaudited financial results for the second quarter ended June 30, 2013.

Financial Highlights

•Second quarter 2013 DIFICID net product sales in the U.S. and Canada of $19.0 million, compared to $15.2 million in the corresponding quarter in 2012, and up 13% from $16.8 million in the first quarter

Help employers find you! Check out all the jobs and post your resume.

Back to news